Step 1: Whether you want the ductus arteriosus open or closed determines the drug class. To hold the duct open in duct-dependent lesions, a prostaglandin E1 analogue is given because PGE-1 directly dilates ductal tissue.
Step 2: The PGE-1 agents used clinically for this are alprostadil and misoprostol. Of the listed choices, misoprostol fits this role, so it is the answer.
Step 3: By contrast, to shut a patent duct in a premature baby, prostaglandin synthesis inhibitors like indomethacin or ibuprofen are used, which is the reverse pharmacological action.
Step 4: The remaining options, anaprostone, danaprostone and PGE-2, are not the recognised analogues for maintaining patency, confirming misoprostol as correct.
\[\boxed{\text{Misoprostol}}\]